EBS — Emergent BioSolutions Inc. stock price, charts and financials

QT34Emergent BioSolutions Inc.

Emergent BioSolutions Inc. (NYSE: EBS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.47
-0.37-7.72%
OverviewShort InterestFilings
EBSQT34Emergent BioSolutions Inc.·NYSE
4.47-7.72%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 06, 202610-QQuarterly report
Aug 05, 20268-KCurrent report
Jul 31, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 02, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 01, 20264Statement of changes in beneficial ownership
May 01, 20264Statement of changes in beneficial ownership
May 01, 20264Statement of changes in beneficial ownership
May 01, 20264Statement of changes in beneficial ownership
May 01, 20264Statement of changes in beneficial ownership
May 01, 20264Statement of changes in beneficial ownership
#1 / 25 of 429
Page
▼
/ 18